Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid

Alcohol
M E HillbomM Kaste

Abstract

To evaluate the value of the nonsedative anticonvulsants carbamazepine and valproic acid a controlled study including drug monitoring was carried out. Intoxicated alcoholics (n = 138) were admitted for inpatient detoxication and randomly assigned to either carbamazepine (n = 43), sodium valproate (n = 46) or placebo (n = 49) in a double-blind fashion. Drug treatment lasted for four days and the daily doses of both drugs amounted to 1200 mg in the beginning of the study. Sodium valproate induced gastric distress, nausea and vomiting more frequently than placebo. About half of the subjects had to stop carbamazepine because of intolerable side-effects including vertigo, nausea, vomiting, diplopia and rash. Serum carbamazepine levels (18-89 mumol/l) were found to be high (greater than 40 mumol/l) in many but not all of these subjects. Seizures occurred in 3 subjects on placebo, 2 on carbamazepine and 1 on sodium valproate. Delirium tremens developed in 2 on sodium valproate and 1 on placebo. The study demonstrates that drug side-effects may seriously hamper the utility of carbamazepine and sodium valproate as routine treatment for the prevention of alcohol withdrawal symptoms.

References

Jan 1, 1984·Acta Neurologica Scandinavica·M E Hillbom, M Hjelm-Jäger
Sep 1, 1980·The Australian and New Zealand Journal of Psychiatry·D G LambieE A Whiteside

❮ Previous
Next ❯

Citations

Jul 27, 2001·Current Psychiatry Reports·D M Greenberg, J W Lee
Sep 18, 2012·Current Psychiatry Reports·Conor K FarrenRoger D Weiss
Mar 1, 1994·Journal of Substance Abuse Treatment·F T Miller
Mar 1, 1996·Journal of Clinical Forensic Medicine·P Naik, J Lawton
Feb 23, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Florian EyerThomas Zilker
May 12, 2006·The Neurologist·Panayiotis N Varelas, Marianna Spanaki
Oct 5, 2001·Alcoholism, Clinical and Experimental Research·J P ReouxK L Sloan
Jan 9, 2014·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Barbora MainerovaRomana Bradacova
Nov 26, 2010·Journal of Clinical Psychopharmacology·Christoph RichterMartin Schaefer
Dec 18, 2015·Psychosomatics·Yelizaveta SherJosé R Maldonado
Nov 22, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Lorenzo LeggioRobert M Swift
Sep 20, 2012·Journal of Psychiatric and Mental Health Nursing·E Cooper, J Vernon
May 12, 2010·Journal of Clinical Pharmacy and Therapeutics·R Barrons, N Roberts
Oct 19, 2006·The Journal of Emergency Medicine·Niels K RathlevGail D'Onofrio
Dec 11, 2003·Obstetrics and Gynecology Clinics of North America·Michael P Bogenschutz, Cynthia M A Geppert
Apr 1, 1994·Annals of Medicine·V OzdemirC A Naranjo
May 11, 2005·Expert Opinion on Investigational Drugs·Sarah W Book, Hugh Myrick
Apr 22, 2015·CNS Drugs·Christopher J HammondAlbert J Arias
Mar 2, 2006·The Annals of Pharmacotherapy·Elaine LumRichard S Slavik
May 24, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Valerie Prince, Kelly R Turpin
Jan 1, 1998·International Journal of Psychiatry in Clinical Practice·J HoriguchiS Yamawaki
Jan 4, 2001·Substance Use & Misuse·B K Boyarsky, E F McCance-Katz
May 24, 2019·The Journal of Neuropsychiatry and Clinical Neurosciences·Ricardo E JorgeStephan Arndt
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Silvia MinozziMarina Davoli
Jan 26, 2000·Journal of Clinical Psychopharmacology·L L DavisF Petty
Mar 16, 2001·Bipolar Disorders·I M Salloum, M E Thase
Nov 7, 2007·CNS Spectrums·Jennifer M Rosenberg, Carl Salzman
Aug 1, 2015·World Journal of Gastroenterology : WJG·María Luisa Gutiérrez GarcíaConrado M Fernández-Rodríguez
Apr 24, 2010·CNS Spectrums·Icro MaremmaniHagop Akiskal
Nov 4, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A S Kotov
Sep 1, 1993·The Journal of Emergency Medicine·E S Freedland, D B McMicken

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.